Considerations for the Use of Polysorbates in Biopharmaceuticals
| Autor: | Atanas Koulov, Maloney Kevin, Wei Liu, Alexander M. Harmon, Hanns-Christian Mahler, Dilbir S. Bindra, Ping Y Yeh, Kapil Gupta, Sandeep Yadav, Vincent Corvari, R. Matthew Fesinmeyer, Michael T. Jones, John Wang, Satish K. Singh, Kenneth D Hinds |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Computer science
Drug Compounding Pharmacology toxicology Polysorbates Pharmaceutical Science 02 engineering and technology 030226 pharmacology & pharmacy Excipients 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Drug Stability Animals Humans Pharmacology (medical) Particle Size Pharmacology Polysorbate Biological Products Protein Stability Hydrolysis Organic Chemistry Proteins 021001 nanoscience & nanotechnology Biopharmaceutical chemistry Molecular Medicine Polysorbate 20 Biochemical engineering 0210 nano-technology Oxidation-Reduction Biotechnology |
| Zdroj: | Pharmaceutical Research. 35 |
| ISSN: | 1573-904X 0724-8741 |
| DOI: | 10.1007/s11095-018-2430-5 |
| Popis: | Polysorbates are commonly added to protein formulations and serve an important function as stabilizers. This paper reviews recent literature detailing some of the issues seen with the use of polysorbate 80 and polysorbate 20 in protein formulations. Based on this knowledge, a development strategy is proposed that leads to a control strategy for polysorbates in protein formulations. A consortium of Biopharmaceutical scientists working in the area of protein formulations, shared experiences with polysorbates as stabilizers in their formulations. Based on the authors experiences and recent published literature, a recommendation is put forth for a development strategy which will lead into the appropriate control strategy for these excipients. An appropriate control strategy may comprise one or more elements of raw material, in-process and manufacturing controls. Additionally, understanding the role, if any, polysorbates play during stability will require knowledge of the criticality of the excipient, based upon its impact on CQAs due to variations in concentration and degradation level. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink